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Aims To evaluate the feasibility of loading resting monocytes/macrophages by intravenous (i.v.) injection of fluorescent iron
oxide nanoparticles prior to injury and tracking of these cells in the very same animal to myocardial infarction (MI) by
magnetic resonance imaging (MRI) and optical imaging.
Methods
and results
Rats were injected with fluorescent iron oxide nanoparticles (10 mg/kg) (n ¼ 15) prior to injury. After disappearance
of the nanoparticles from the blood, MI was induced. Monocytes/macrophages were then tracked in the very same
animal by MRI and optical imaging. Control groups were (i) non-injected animals (n ¼ 15), (ii) injected animals associ-
ated with a sham operation (n ¼ 8), and (iii) animals treated with an anti-inflammatory agent (n ¼ 6). The presence of
iron-loaded cells can be detected by MRI in vivo in the infarcted myocardium. Here, we showed that the detection of
inflammatory cells in vivo correlated well with ex vivo imaging (MRI and reflectance fluorescence) and histology. We
also showed that the method is robust enough to depict changes in the inflammatory response.
Conclusion This study demonstrates that resting monocytes/macrophages can be loaded in vivo by a simple i.v. injection of flu-
orescent superparamagnetic iron oxide nanoparticles prior to injury and then tracked, in the same animal, in a
model of ischaemia–reperfusion leading to myocardial infarct. Although previous studies of macrophages infiltration
following MI have labelled the macrophages after injury, this study, for the first time, has pre-load the resting mono-
cytes with fluorescent iron oxide nanoparticles.
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Introduction
The inflammatory response following myocardial infarction (MI) is
well documented.1 – 3 Pro-inflammatory cytokines, like TNF-a,
IL-1b, and IL-6 are found in MI within the first hours to the first
days. Monocyte chemoattractant protein-1 (MCP-1) is also
up-regulated in MI.4,5 Altogether, these cytokines attract
inflammatory cells into the MI zone, including mast cells and
monocytes/macrophages. Once these cells have transmigrated
into the MI, they will also produce cytokines and the heart
enters into a vicious cycle of cytokine amplification that could be
either favourable, leading to healing, or deleterious, leading to
heart remodelling and ultimately to heart failure. Hence, in vivo
visualization of inflammatory cells after MI would be of primary
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importance to better define at which time the inflammatory
response is favourable or deleterious.
Distinguishing cells of interest from complex background implies
that cells have to be tagged with a contrast medium that could be
observed through imaging modalities. Many reports used ex vivo
cell loading with transfection agents and have already proven
that cell tracking can be realized in vivo.6 Nevertheless, the use of
transfection agents is not straightforward7 and ex vivo manipulation
of cells can activate and/or modify their biological behaviour.8
From this point of view, it would be interesting to load the cells
in vivo and to track them in vivo in the same animal. It is well
known that nanoparticles are cleared from the blood by the reti-
culoendothelial system (RES).9 Hence, the monocytes/macro-
phages system could be loaded in vivo by a simple intravenous
(i.v.) injection of nanoparticles.
Iron oxide nanoparticles are potent contrast agents for magnetic
resonance imaging (MRI) and are FDA approved for clinical use.
Magnetic resonance imaging is a modality of choice for in vivo
imaging because the technique is (i) non-invasive, allowing serial
imaging of the very same animal, (ii) non-ionizing, and (iii) sensitive
enough to detect iron-loaded cells in a living animal,9 as well as in
human.10
The goal of this paper was to load resting monocytes/macro-
phages in vivo with fluorescent iron oxide nanoparticles before
inducing an inflammatory lesion in rats. Once the nanoparticles
have been cleared from the plasma, an ischaemia–reperfusion
episode of the heart was realized to induce an acute and localized
inflammation. The monocytes/macrophages infiltration of the MI
was then tracked in vivo by MRI in the very same animal and cell
infiltration confirmed by ex vivo MRI, reflectance fluorescence,
and histology.
Methods
Fluorescent iron oxide nanoparticles
To synthesize fluorescent iron oxide nanoparticles, superparamagnetic
iron oxide nanoparticles (SPION) containing amino groups on their
surface, synthesized as described previously,11,12 were reacted with
N-hydroxysuccinimide ester of FluoProbes 565 (absorption ¼
563 nm/emission ¼ 592 nm) (Fluoprobes, Interchim, France). There
were 1000 amino groups on each nanoparticle with four to five
amines consumed for the attachment of the fluorophores.
Plasma half-life and whole blood fluorescence
All animal experiments were approved by the Ethics Committee of our
university and were in accordance with the Swiss guidelines for animal
experiments.
To determine whole blood fluorescence and plasma half-life of the
nanoparticles, 10 mg/kg of fluorescent SPION were injected into the
tail vein of Sprague–Dawley rats weighing 322+12 g (n ¼ 2). Two
hundred microlitres of blood were collected in heparinized tubes
before, immediately after i.v. injection, and at 2, 4, 8, 24, and 48 h post-
injection. Whole blood and plasma (obtained after 12 min centrifu-
gation at 500 g) optical density was read at 563 nm on a DU 730
spectrophotometer (Beckman–Coulter, Fullerton, CA, USA). To
determine in which cells the fluorescence reappeared in whole
blood, leucocytes were purified on Ficoll gradient (Ficoll-Paque
PLUS, GE Healthcare, Uppsala, Sweden) and then analysed by
immunohistochemistry against CD68 (and against PMN, data not
shown) (see below).
Animal model of ischaemia–reperfusion
All surgeries, i.v. injection, and MRI were realized under 2–3% isoflur-
ane inhalation anaesthesia (Isoflurane, Baxter, IL, USA).
Under isoflurane anaesthesia, tracheal intubation, and mechanical
ventilation, the left femoral artery was cannulated to allow continuous
monitoring of arterial pressure. A three-lead electrocardiogram (ECG)
using subcutaneous electrodes was placed, allowing monitoring the
ischaemia in real time. A balanced electrolyte solution (0.5 mL/100 g/h)
was infused to compensate for insensible fluid losses. After an i.v.
bolus of fentanyl (10 mg/kg) for supplemental analgesia, the heart
was exposed through a left thoracotomy. A 6-0 polypropylene
suture was placed around the left anterior descending (LAD) coronary
artery close to its origin and maintained occluded for 30 min. The
occlusion of the LAD coronary artery was confirmed by ECG
changes (ST-segment elevation), regional cyanosis, and akinesia of
the anterior ventricular area. After 30 min of ischaemia, the polypro-
pylene suture was completely removed, allowing reperfusion.
After haemodynamic stabilization (30 min), the chest was closed. To
alleviate post-operative pain, the wounds were infiltrated with a local
anaesthetic (bupivacaine 0.125%, 1 mL) and buprenorphine (0.05 mg/
kg every 12 h for 48 h) was injected subcutaneously. After full anaes-
thesia emergence, the rats were closely monitored and allowed free
access to standard rat chow and water.
Animal groups
Animals were divided into four groups. The first one (n ¼ 15, weighing
310+8 g) received an i.v. injection of fluorescent SPION (10 mg/kg)
3 days before the ischaemia–reperfusion. Magnetic resonance
imaging was performed on this group every day from Days 0 to
3. Each day, three animals were sacrificed for subsequent ex vivo
imaging and histological correlation. This group was denoted
SPION_MI. The second group (n ¼ 15, weighing 329+ 13 g) was
not injected with fluorescent SPION but underwent the same ischae-
mia–reperfusion protocol as the SPION_MI group and was also
imaged from Days 0 to 3. Each day, three animals were sacrificed for
subsequent ex vivo imaging and histological correlation. This group
was denoted Ø_MI. The third group (n ¼ 8, weighing 317+15 g)
received an i.v. injection of fluorescent SPION (10 mg/kg) 3 days
before surgery. For this group, the 6-0 polypropylene suture was
placed around the LAD but not closed (¼Sham group), denoted
SPION_Sham. Magnetic resonance imaging was acquired from Days
0 to 3. Animals were sacrificed at Day 0 (n ¼ 2) and Day 3 (n ¼ 6).
The fourth group (n ¼ 6, weighing 311+ 16 g) was injected with flu-
orescent SPION (10 mg/kg) 3 days before surgery. This group under-
went the same ischaemia–reperfusion as the SPION_MI and Ø_MI
groups but received an anti-inflammatory treatment immediately
after the beginning of the reperfusion. The anti-inflammatory treat-
ment consisted of an intraperitoneal (i.p.) injection of 333 mg/kg of
[44AANA47]-RANTES, a potent anti-CCL5 agent.13 This group was
denoted SPION_MI_AntiCCL5. All animals were sacrificed after the
last imaging session by i.v. injection of KCl (200 mEq/kg). The heart
was then imaged ex vivo by fluorescence imaging and by MRI. At the
end of the ex vivo imaging session, the heart was quick-frozen and
stored at 2808C for subsequent histological analysis.
Magnetic resonance imaging
All images were acquired on a clinical scanner at 1.5 T with a dedicated
microscopic surface coil (47 mm diameter) (Philips Medical System,
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Best, The Netherlands). Our experimental settings have already been
published.14 Briefly, the rats were placed in a cradle in prone position.
A rectal thermal probe with a heating system was used to maintain the
temperature of the rats constant (37.0–37.58C), a respiratory pillow
was placed on the abdomen to measure breathing rate. Subdermal
electrodes were placed to record an ECG used as a cardiac trigger
for the MR system. The monitoring devices were connected with
optical fibres to a computer during the MRI acquisitions [SA Instru-
ment, Inc. (SAII), Stony Brook, NY, USA, MR-Compatible Model
1025 Monitoring and Gating System]. Using this set-up, the physiologi-
cal parameters of the rats were continuously measured in real time
during the whole experiment.
Cine imaging was realized using a prospective ECG-triggered seg-
mented turbo field echo cine sequence, TR/TE 12/4.9 ms. Flip angle
(FA) 308, 288  288 matrix sampled on a Cartesian grid, 80 mm
field of view (FOV), and 2 mm slice thickness yielding an in plane res-
olution of 280  280 mm. Eleven to 20 cardiac phases where acquired
per R-R cycle depending on the heart rate. Two short axial planes, as
well as two- and four-cavity views, were acquired for each animal.
Tagged MRI was obtained by using a C-SPAMM tag preparation seg-
mented cine fast field echo (FFE) sequence,15,16 TR/TE 7.8/3.6 ms, tag
spacing 1 mm, acquired voxel size 0.31  0.31  3 mm, and FA 108.
The inter image time was about 8 ms yielding to 18–25 phases per
cardiac cycle. Six short axis levels were acquired on each animal.
Fast field echo sequence was used for iron oxide particles detection;
TR/TE1/TE2 350/7/15 ms; FA 508, 395  608 matrix sampled on a
Cartesian grid, 120 mm FOV, and 2 mm slice thickness with a negative
gap of 21 mm yielding an in plane resolution of 200  300 mm.
Multi-echo spin echo sequence was used to calculate T2 relaxation
time; TR/TEmin/TEmax 520/5.9/94.4 ms with 16 echoes in-between,
256  256 matrix sampled on a Cartesian grid, 80 mm FOV, and
3 mm slice thickness yielding an in plane resolution of 310 
310 mm. T2 values were calculated according to the equation: signal
intensity ¼ M0(e2TE/T2), where M0 is the initial magnetization, TE is
the time of echo.
Total imaging time was ,1 h per animal.
Global cardiac function analysis
The left ventricle ejection fraction (LVEF) was assessed for each animal
with MR cine images according to: LVEF (%) ¼ (Vdiast2 Vsyst)/Vdiast.
End-diastolic (Vdiast) and end-systolic (Vsyst) volumes were calculated
by manually drawing endocardial contours and long axis length at end-
diastolic and end-systolic phases for each axis. End-diastolic and end-
systolic volumes were calculated according to the Simpson’s modified
method:17,18 volume ¼ (length/2)  (Abasalþ 2/3  Aapex) with Abasal,
diastolic or systolic basal area; Aapex, diastolic or systolic area; length,
diastolic or systolic long axis length.
Regional cardiac function by tag analysis
The tag analysis was performed with the Extrema Temporal Chaining
algorithm.19 Extrema Temporal Chaining algorithm consists in tracking
points of tag and crest lines along their orthogonal direction by a tem-
poral chaining. These points are detected as local minima and maxima
of 1D signals corresponding to lines or columns of the 2D images. In
parallel, a spatial smoothness assumption of the deformation field and
to the myocardial boundaries is incorporated to prevent abnormal
extrema matching. Starting from a spatial chaining on the first image,
real 2D displacements are computed on extrema locations. Finally, dis-
placements of all the myocardium points are interpolated via the
Laplace equation. Circumferential strains (CS) are then averaged in
12 sectors. Maximum of the CS were measured in the midwall (by
dividing the wall thickness in thirds) in per cent according to the
formula: %CS ¼ (CSsyst2 CSdias).
Ex vivo fluorescence imaging
The heart was explanted, rinsed in NaCl 0.9%, and imaged with an
IVIS-200 system (Calipers live science AG, Switzerland) using filters
of 500–550/575–650 (abs/em). Images were digitally acquired as
16-bit images on a cooled-CCD camera.
Ex vivo magnetic resonance imaging
The heart was placed inside a test tube containing NaCl 0.9% and
scanned again with a surface microscopic coil of 23 mm diameter uti-
lizing the same FFE sequence as in vivo, but at higher resolution. The
in-plane resolution was 100  100 mm and the slice thickness 2 mm.
Histological staining
Frozen hearts were cut on a CM3050 cryostat (Leica Microsystems
GmbH, Germany). Ten slices of 6 mm every millimetre were collected.
Sections were stained with haematoxylin–eosin for morphological
analyses; Masson’s trichrome for fibrosis quantification and Prussian
Blue for iron detection.
Fibrosis was evaluated by hand drawing region of interest. The
volume of fibrosis was normalized by the volume of the LV.
Immunohistochemistry was realized on acetone-fixed cryosections,
which were blocked with PBS containing 2% BSA, and incubated for
2 h with a mouse anti rat CD68 diluted 1:1000 (Abd Serotec,
Oxford, UK). A secondary antibody (goat anti mouse-FITC, Jackson
Immunoresearch Europe) was applied at 1:100 for 1 h. Nuclear staining
was obtained with a mounting media containing DAPI (Vectashield
hard set with DAPI, Vector Laboratories, Burlingame, CA, USA).
Control sections were processed identically, with the exception of
omitting the incubation with the primary antibody. The controls
never showed specific binding.
Monocytes/macrophages numbers per FOV (400) were counted.
Three FOV per level were used to average the number of
CD68-positive cells present in the myocardial infarct.
Co-localization of CD68-positive cells with fluorescent SPION was
automatically analysed and measured on histological slices with the
TissueQuest software (TissueQuest, TissueGnostics, Vienna, Austria).
The software allows to automatically detect nuclei of all cells based
on nuclear fluorescence. Once all individual nuclei are identified, a
measure mask based on all cytoplasmic stainings is automatically gen-
erated (the automatically generated measure mask is staining-
dependent in its extension and adjustable to the appropriate cell
size). The software then automatically measures the intensity for
each channel and depicts co-localization of different fluorescent
markers in form of scatter diagrams (FACS-like presentation).20 The
statistics including mean intensity are generated automatically after
manual setting of cut-offs.
Statistical analysis
Statistical analysis was performed with Prism (Prism, version 4a, 2003;
GraphPad Software, San Diego, CA, USA) and statistica (Statistica
version 8, Statsoft Inc., Tulsa, OK, USA). Results are presented as
mean+ SD. All normally distributed data sets (established from Kol-
mogorov–Smirnov tests) were compared using analysis of variance
with Newman–Keuls post hoc test; non-normally distributed data
sets were compared using Wilcoxon rank-sum test. Two-sided
testing was used. Differences were considered significant at P, 0.05.
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Results
Plasma and whole blood fluorescence
The plasma half-life of the fluorescent SPION was 328+ 65 min in
rats (Figure 1). The fluorescence measured on whole blood
demonstrated a decrease in fluorescence over the first 18 h fol-
lowed by an increase in fluorescence from Day 1 on (Figure 1).
This kinetic corresponded to the disappearance of the fluor-
escent SPION from plasma and to the reappearance of fluorescent
SPION inside cells (as measured in whole blood). The fluorescent
SPION were associated with CD68-positive cells (monocytes/
macrophages), but not with PMN. Hence, an i.v. injection of
fluorescent SPION allowed loading the resting monocytes/
macrophages in vivo. The liver and the spleen were also highly
fluorescent (data not shown) and served as control for the i.v.
injection of the fluorescent SPION.
Monocytes/macrophages tracking by
magnetic resonance imaging
A delay of 3 days between i.v. injection of florescent SPION and
ischaemia–reperfusion was used to allow for a complete disap-
pearance of nanoparticles from the plasma. All animals in the
SPION_MI group demonstrated a clear hypointense (black) signal
in the MI area, whereas animals in the Ø_MI group never
showed the hypointense signal (Figure 2). Magnetic resonance
imaging acquired ex vivo correlated well with in vivo imaging, con-
firming the presence of a hypointense signal in the injected
group and no hypointense signal in the non-injected group.
Ex vivo fluorescence showed accumulation of fluorescence with
time into the MI in the SPION_MI group, but showed no fluor-
escence in the Ø_MI group (Figure 2).
Hence, in vivo and ex vivo imaging were capable of depicting gradual
infiltration of pre-loaded monocytes/macrophages into the MI.
Figure 1 Plasma and whole blood fluorescence. Time course of fluorescent superparamagnetic iron oxide nanoparticles absorption in plasma
(A) and whole blood (B). Plasma half-life was 328+65 min. After an initial decrease in the fluorescence in whole blood, fluorescence reap-
peared (B) and is clearly associated with CD68-positive circulating cells (C). Hence, an intravenous injection of fluorescent superparamagnetic
iron oxide nanoparticles allowed in vivo loading of monocytes.
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Global cardiac function analysis
The global cardiac function was assessed through EF (Table 1). The
EF of the SPION_Sham group was always higher than all other
groups, reaching the statistical threshold only at Day 0. Neverthe-
less, one can see that the thoracotomy induces stress in the animal
and that it takes 3 days for a normalization of the cardiac function.
There were no statistical differences between the SPION_MI
and the Ø_MI groups, indicating that the injection of iron per se
has no impact on global cardiac function. The EF of the
SPION_MI_AntiCCL5 group was higher than the SPION_MI
group, without reaching the statistical level. As the primary goal
of this paper was to image the inflammatory response following
MI, we did not make any effort to optimize the antiCCL5 treat-
ment. This will have to be done in future studies.
Regional cardiac function analysis
Regional cardiac function was assessed through MR tag analysis.
The hypointense (black) signal appearing in the antero-lateral
Figure 2 In vivo and ex vivo imaging. In vivo magnetic resonance imaging of the infarcted groups is presented in (A). The first line corresponds to
a representative rat of the SPION_MI group and clearly shows the appearance over time [Day (D) 0 to D3] of a hypointense (black) signal in the
myocardial infarction area (arrows). As discussed, the appearance of the hypointense signal is due to the superparamagnetic iron oxide. The
second line corresponds to a representative rat of the Ø_MI group and does not show any hypointense signal. Ex vivo magnetic resonance
imaging (last column) also depicts a clear hypointense signal in the SPION_MI rat, whereas no hypointense signal was seen in the Ø_MI,
thus confirming the in vivo results. Ex vivo reflectance fluorescence (B) also confirmed the magnetic resonance results. A representative
image of the injected group shows a clear increase in fluorescence over time, whereas the non-injected group does not show any fluorescent
signal.
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Table 1 Ejection fraction
Ejection fraction (%)
D0 D1 D2 D3
SPION_Sham
*j
j76+4 77+3 79+5 82+5
SPION_MI j53+11 62+11 65+12 67+13
Ø_MI 58+8 65+8 70+11 68+13
SPION_MI_AntiCCL5 63+9 70+10 72+6 72+7
*P, 0.05.
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wall of the LV corresponded well with the hypokinetic part of
the LV (Figure 3). Moreover, statistical analysis revealed a clear
contraction difference (P, 0.02) between the normal and
hypointense part of the LV (Figure 3).
Hence, the appearance of a hypointense signal corresponds to
the appearance of iron, which in turn corresponds to the hypoki-
netic part of the LV and hence to MI.
Quantitation of the infiltration
Quantitation by histology
Immunohistochemistry against CD68-positive cells was used to
quantify infiltration of the MI by monocytes/macrophages
with time. Infiltration followed an exponential pattern from
Days 0 to 3 (Figure 4). There were no differences in the
number of monocytes/macrophages counted in the MI between
the SPION_MI and the Ø_MI groups (P. 0.5) (Figure 4A). The
number of monocytes/macrophages counted in the SPION_-
MI_antiCCL5 group was significantly lower than in the
non-treated groups (P, 0.001) (Figure 4A). No monocytes/
macrophages were seen in the myocardium of the SPION_Sham
group.
Quantitation by magnetic resonance imaging
The acquisition of parametric T2 map allowed calculating T2 relax-
ation time. It is known that superparamagnetic iron oxide has a
strong effect on T2 relaxation time. The more the iron, the
shorter the T2 and the bigger the 1/T2.21 The quantitation of
iron content in the MI correlated well with the number of macro-
phages present in the MI in histology (Figure 4C and Table 2). More-
over, the intermediate number of monocytes/macrophages seen in
the SPION_MI_AntiCCL5 group, corresponded to an intermediate
1/T2 value (Figure 4 and Table 2). Nevertheless, further studies will
be needed to directly compare the accuracy of MRI to quantify
monocytes/macrophages infiltration with a classical gold standard
such as immunohistology.
Different groups at Day 3
The SPION_MI group, showed clear infarcted area by MRI (akine-
sia of the antero-lateral wall) and by histology (fibrosis ¼ 17.7+
3.4) at Day 3, as well as CD68-positive cells, containing iron
(Figure 5). The Ø_MI group showed clear infarcted areas by MRI
and by histology (fibrosis ¼ 19.6+8.2) containing numerous
monocytes/macrophages, but iron oxide was never detected.
The SPION_Sham group never showed signs of infarct, nor
Figure 3 Regional cardiac function. Representative case of the SPION_MI groups. Magnetic resonance imaging are presented from Days 0 to
3 (first line), as well as colour-coded map of circumferential shortening (second line, akinesia been coded in blue and normal contraction being
coded in red) and tag analysis (third line). This figure demonstrates that the hypointense (black) region corresponds to the hypokinetic part of
the left ventricle and hence represents the arrival of iron in the myocardial infarction. Please note that the contraction of the hypointense region
was always statistically different from the contraction of the remote region (P, 0.02, at least).
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monocytes/macrophages infiltration. The SPION_MI_AntiCCL5
group showed smaller infarcted area by MRI and by histology
(fibrosis ¼ 10.7+5.5), with less numerous monocytes/macro-
phages infiltration than in the non-treated groups. The fibrosis of
the SPION_MI-AntiCCL5 group was smaller than the fibrosis
of both SPION_MI and Ø_MI (P, 0.05), and the number of
CD68þ cells seen in SPION_MI_AntiCCL5 was also smaller
than in the SPION_MI and Ø_MI groups (P, 0.001).
Automatic determination of loaded
monocytes/macrophages on histological
slices
Co-localization of CD68-positive cells with fluorescent SPION
showed that the SPION_MI group had a mean loading of mono-
cytes/macrophages of 81% (Figure 6). The Ø_MI group showed
no loaded monocytes/macrophages. The SPION_Sham group
showed no inflammatory cells infiltration. The SPION_MI_An-
tiCCL5 group showed a mean loading of monocytes/macrophages
of 79%, which was not different from the SPION_MI group (P .
0.5), allowing to directly compare the T2 values (or 1/T2)
between both groups. Having the same loading, so the same quan-
tity of iron, changes in T2 (or 1/T2) reflects changes in cell
numbers. Hence, the intermediate change of T2 (or 1/T2) in the
SPION_MI_AntiCCL5 group corresponds to a lower monocytes/
macrophages infiltration (when compared with the SPION_MI
group).
Discussion
Iron oxide nanoparticles are cleared from the plasma by the RES.
Part of the RES consists of resident macrophages of the liver
(Kupffer cells). Even if these cells are clearly loaded with iron
(data not shown), they will never be able to infiltrate inflammatory
lesions, because they are incapable of leaving the liver (resident
macrophages). Another part of the RES is formed by the mono-
cytes. These cells are also loaded with fluorescent SPION
(Figure 1) and, as they have the propensity to circulate, they are
able to infiltrate inflammatory lesions.
All the papers previously published on iron oxide nanoparticles
and imaging used an i.v. injection of the nanoparticles after
Figure 4 Monocytes/macrophages quantification. Monocytes/macrophages infiltration on histological myocardial slices is presented in (A).
The infiltration showed an exponential growth over time. There was no difference in cellular infiltration between the SPION_MI and the
Ø_MI groups, whereas the SPION_MI_AntiCCL5 showed a statistically lower monocytes/macrophages infiltration at Day 3 (P, 0.001).
The quantitation of the 1/T2 values (B) correlated well with histological data (C). Hence, quantitation of the monocytes/macrophages infiltration
of myocardial infarction in vivo by magnetic resonance imaging provides an excellent estimate of the number of macrophages, with an error
,3%. Dashed line corresponds to 95% confidence interval.
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induction of the pathological process, in already activated mono-
cytes22,23 or ex vivo cell loading.6 As far as we know, no other
studies report the use of iron oxide nanoparticles injection
before the induction of an inflammatory lesion. This study was
designed to first load the resting RES, to wait for the complete dis-
appearance of the nanoparticles from the plasma, and then track
the monocytes/macrophages cells up to an inflammatory lesion
in the same animal.
The blood half-life of the fluorescent SPION we used was
328 min. By waiting 3 days between the i.v. injection and the cre-
ation of the inflammatory lesion, we can expect ,0.025% of the
injected dose to remain in plasma (3 days correspond to .12
plasma half-lifes). Hence, if iron appears in the inflammatory
lesion, it could not originate from a simple extravasation from
the blood.
Moreover, we have demonstrated that the i.v. injected fluor-
escent SPION reappeared in the circulating monocytes (and only
monocytes) after 1–2 days. Hence, appearance of iron in the
inflammatory lesion is due to monocytes/macrophages infiltration.
One major advantage of this approach, when compared with an
injection of iron oxide nanoparticles after the beginning of the
inflammatory process, is that appearance of iron in the lesion
could only be due to infiltration of monocytes/macrophages. In
the studies where the nanoparticles were injected after the begin-
ning of the inflammatory process, the presence of iron could be
due to two main mechanisms: (i) iron could extravasate and be
endocytosed by macrophages already in the lesion and (ii) circulat-
ing monocytes could also be loaded during their blood residency
time and then extravasate. Hence, this type of experiments does
not allow to differentiate infiltration of newly loaded monocytes/
macrophages from phagocytosis by resident macrophages of
newly extravasated iron.
Cell tracking by MRI is a well-known technique.6,24 For a specific
cell (or a cluster of cells) to be distinguished from the complex
anatomical background, the cell should contain a contrast
medium visible by a given imaging modality. Such contrast
medium for MRI includes gadolinium chelate, manganese, and
iron oxide nanoparticles. We chose iron oxide nanoparticles for
multiple reasons. First, as previously stated, iron oxide nanoparti-
cles are cleared from the blood by the RES, allowing in vivo
loading of the monocytes/macrophages. Secondly, the synthesis
of fluorescent iron oxide nanoparticle was published,25 allowing
multimodal imaging and correlative histology. Thirdly, iron oxide
nanoparticles are non-toxic for the cells and are not known to
induce inflammation per se.26 Hence, using fluorescent SPION
allowed combining the advantage of in vivo imaging by MRI (using
the iron as contrast medium) with the cellular localization obtained
by fluorescence microscopy (using fluorophores as contrast
media).
Ischaemia leading to infarction results in an inflammatory
response. This response is accelerated and amplified in the case
of reperfusion.27 Mononuclear cells infiltration of the MI is gov-
erned sequentially by different proteins and chemokines. In the
first few hours, C5a is wholly responsible for the mononuclear
cells infiltration. After 60–180 min, transforming growth factor
b1 (TGFb1) contributes significantly to the chemotactic activity.
After 180 min, MCP-1 acting together with TGFb1 has a major
role.1,3,28 The majority (in terms of number) of inflammatory
cells found in MI are macrophages, with a peak occurring
between Days 3 and 4.27,29 The presence of .1000 macro-
phages/mm2 in the MI would facilitate their detection. As the
maximal infiltration appeared around Days 3–4, animals were
only sequentially studied for 4 days in this study (from Days 0 to 3).
In our model of ischaemia–reperfusion, a clear hypointense
signal was detected over time in the MI, corresponding to infiltra-
tion of iron-loaded monocytes/macrophages. The presence of flu-
orescent SPION was detectable in vivo, ex vivo (by MRI and
fluorescent imaging), and by histology. An anti-CCL5 treatment
induced a lower monocytes/macrophages infiltration and a
smaller infarct.
Despite the smaller MI, the anti-CCL5-treated groups did not
show a better cardiac function than the untreated group. Never-
theless, as the primary goal of this study was to image the inflam-
matory process, we have not optimized the anti-inflammatory
treatment. The animals received only one injection of the anti-
inflammatory treatment during the reperfusion. Future studies
aiming at determining the best anti-inflammatory treatment proto-
col has to be done, i.e. determine the dose and timing of anti-CCL5
injection for an optimal effect. Furthermore, the research group
directed by Prof. Mach have recently tested the treatment with
anti-RANTES agents in a mouse model of myocardial ischaemia–
reperfusion. The results showed that a single i.p. injection of a
Table 2 T2 and 1/T2 values in the myocardial
infarction and in the remote zone
All values were statistically different from the remote region except: SPION-MI
was not different from all remote and SPION-MI-AntiCCL5-D3 was not different
from remote-D2 and -D3.
*P, 0.05.
**P, 0.001.
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RANTES Antagonist (AANA-RANTES) performed during ischae-
mia (5 min before the reperfusion) significantly reduces infarct
size in wild type and apolipoproiten (Apo)E2/2 mice (unpublished
data). This effect may be related to the diminished leucocyte infil-
tration into the ischaemic myocardium during the reperfusion
period (unpublished data).
Reperfusion inflammatory injury is considered an important
factor in myocardial deterioration after acute coronary syndrome
(ACS). Both local and systemic inflammatory reactions play a
crucial role in this process. Indeed, the inhibition of leucocyte infil-
tration in the infarcted myocardial tissue represents a promising
strategy to reduce reperfusion injury. In particular, the inhibition
of pro-inflammatory molecules such as cytokines and chemokines,
which orchestrate leucocyte trafficking, may be of potential benefit
in post-ischaemic complications, including heart failure. RANTES
has been shown to play a crucial role in the context of ACS.30–32
As many of the treatments used today in the context of MI also
have potent anti-inflammatory effects, including angiotensin-
converting enzyme inhibitors, beta-blockers, and statins,2 imaging
the inflammatory process during the treatment of MI should
improve our understanding of the role of the monocytes/macro-
phages during healing. A recent paper33 suggests that two different
subtypes of monocytes/macrophages are responsible for the early
inflammatory response and for the later ‘reconstructive’ process.
Extracellular matrix degradation and removal of dead cardiomyo-
cytes dominate in the early phase and weakened the heart wall.
Angiogenesis and granulation tissue dominate in the late phase
(after around 5 days) and promote healing. Hence, non-specific
anti-inflammatory treatment should be applied with caution in
the setting of MI. The visualization of monocytes/macrophages
infiltration post-MI could help understanding the role of these
cells in myocardial fate.
As inflammatory response is not only implicated in MI, but also
in oncology34 and rheumatoid arthritis,35 we believe that this
simple method of in vivo cell loading and in vivo cell tracking in
the same animal would be helpful in other important models of
the health problems of our society.
Expected clinical applications
As iron oxide nanoparticles have already been approved or are
investigated in Phase III clinical studies, this paper may yield to
numerous clinical applications. For instance, in the case of
chronic coronary occlusion, revascularization is not performed in
an emergency context but during a scheduled session. Therefore,
monocytes loading using commercially available iron oxide nano-
particle could be performed before the revascularization pro-
cedure and the controversial effect of reperfusion on
inflammatory response could then be studied non-invasively in
patients. Nevertheless, this clinical application will have to be
tested before, because revascularization of chronic coronary
occlusion may not involved ischaemia–reperfusion damage as in
the acute settings.
Figure 5 Comparison of all groups at Day 3. SPION_MI clearly showed a hypointense signal by magnetic resonance imaging (in vivo and ex
vivo) in the myocardial infarction. The fibrosis of this group was calculated to 17.67+ 3.43% (%vol). There were numerous fluorescent-loaded
cells in the myocardial infarction, corresponding to CD68-positive cells. Ø_MI did not show hypointense signal by magnetic resonance imaging,
or iron-loaded cells by histology. The fibrosis was 19.56+ 8.21%. The SPION_Sham group did not show an inflammatory infiltrate or myo-
cardial infarction. The SPION_MI_AntiCCL5 showed a hypointense signal by magnetic resonance imaging, smaller fibrosis (10.67+5.51%)
and less iron-loaded CD68-positive cells in the myocardial infarction. *P, 0.05.
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Conclusion
This study demonstrates that resting monocytes/macrophages can
be loaded in vivo by a simple i.v. injection of iron oxide nanoparti-
cles and then tracked in vivo by MRI in the very same animal in a
rodent model of MI. Ex vivo imaging (MRI and fluorescence) as
well as histology correlated well with in vivo results, with the esti-
mated number of macrophages in vivo by MRI showing ,3% error
compared with histological analysis. Furthermore, the good pre-
cision of the method allowed in vivo follow-up of the amount of
inflammation-induced infiltrating monocytes/macrophages during
an anti-CCL5 treatment.
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